Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Are preventive drugs preventive enough? A study of patients' expectation of benefit from preventive drugs

PN Trewby, AV Reddy, CS Trewby, VJ Ashton, G Brennan and J Inglis
Download PDF
DOI: https://doi.org/10.7861/clinmedicine.2-6-527
Clin Med November 2002
PN Trewby
1Department of Medicine, Darlington Memorial Hospital, Darlington, Co Durham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AV Reddy
1Department of Medicine, Darlington Memorial Hospital, Darlington, Co Durham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CS Trewby
2General practitioner, Darlington
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VJ Ashton
3School of Health and Social Care, University of Teeside
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G Brennan
1Department of Medicine, Darlington Memorial Hospital, Darlington, Co Durham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Inglis
1Department of Medicine, Darlington Memorial Hospital, Darlington, Co Durham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Objectives - The study aimed to find the threshold of benefit for a hypothetical cholesterol-lowering drug below which the subject would not be prepared to take the drug. We also looked at whether proximity to the target event (myocardial infarction) and the subjects' views on drug taking affected this threshold.

Design - We studied 307 subjects using a written questionnaire and interview. Group 1 (102 subjects) had just been discharged from the coronary care unit. Group 2 (105 subjects) were taking cardio-protective drugs but had no recent history of myocardial infarction. Group 3 (100 subjects) had no history of myocardial infarction and were taking no cardio-protective drugs.

Results - Median values for the threshold of benefit below which the subject would not take the preventive drug were 20%, 20%, and 30% absolute risk reduction for Groups 1, 2 and 3 respectively. Median values for expectation of average prolongation of life were 12, 12 and 18 months respectively. Only 27% of subjects would take a drug offering 5% or less absolute risk reduction over five years. Subjects' views on medicinal drug taking in general and proximity to the target event were predictors of the acceptance of preventive drugs. Eighty percent of subjects wished to be told the numerical benefit of a preventive drug before starting on it.

Conclusion - For the majority, the expectation of benefit from a preventive drug is higher than the actual benefit provided by current drug strategies. There is a tension between the patient's right to know about the chance of benefiting from a preventive drug and the likely reduction in uptake if they are so informed.

  • absolute risk reduction
  • atrial fibrillation
  • cholesterol
  • evidence-based medicine
  • hypertension
  • myocardial infarction
  • national service framework
  • patient expectations
  • preventive drugs
  • © 2002 Royal College of Physicians
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Are preventive drugs preventive enough? A study of patients' expectation of benefit from preventive drugs
PN Trewby, AV Reddy, CS Trewby, VJ Ashton, G Brennan, J Inglis
Clinical Medicine Nov 2002, 2 (6) 527-533; DOI: 10.7861/clinmedicine.2-6-527

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Are preventive drugs preventive enough? A study of patients' expectation of benefit from preventive drugs
PN Trewby, AV Reddy, CS Trewby, VJ Ashton, G Brennan, J Inglis
Clinical Medicine Nov 2002, 2 (6) 527-533; DOI: 10.7861/clinmedicine.2-6-527
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Exclusively plant, whole-food diet for polypharmacy due to persistent atrial fibrillation, ischaemic cardiomyopathy, hyperlipidaemia and hypertension in an octogenarian
  • Variation in minimum desired cardiovascular disease-free longevity benefit from statin and antihypertensive medications: a cross-sectional study of patient and primary care physician perspectives
  • Patient preferences for cardiovascular preventive medication: a systematic review
  • Labelling people as 'High Risk: A tyranny of eminence?
  • The numbers needed to inform consent?
  • Patients' Expectations of Screening and Preventive Treatments
  • Dare to tell?
  • Adding "value" to clinical practice guidelines
  • Predictors of patients' preferences for treatments to prevent heart disease
  • Of Struldbruggs, sugar, and gatekeepers: a tale of our times
  • "Polypill" to fight cardiovascular disease: Patients before populations
  • Google Scholar

More in this TOC Section

  • The new UK internal medicine curriculum 
  • The Francis Crick Institute
  • ‘Every breath we take: the lifelong impact of air pollution’ – a call for action
Show more Professional Issues

Similar Articles

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians